NASOPHARYNGITIS is the #17 most commonly reported adverse reaction for CICLESONIDE, manufactured by Covis Pharma US, Inc. There are 995 FDA adverse event reports linking CICLESONIDE to NASOPHARYNGITIS. This represents approximately 1.3% of all 74,022 adverse event reports for this drug.
Patients taking CICLESONIDE who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
NASOPHARYNGITIS995 of 74,022 reports
NASOPHARYNGITIS is a less commonly reported adverse event for CICLESONIDE, but still significant enough to appear in the safety profile.
Other Side Effects of CICLESONIDE
In addition to nasopharyngitis, the following adverse reactions have been reported for CICLESONIDE:
NASOPHARYNGITIS has been reported as an adverse event in 995 FDA reports for CICLESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is NASOPHARYNGITIS with CICLESONIDE?
NASOPHARYNGITIS accounts for approximately 1.3% of all adverse event reports for CICLESONIDE, making it a notable side effect.
What should I do if I experience NASOPHARYNGITIS while taking CICLESONIDE?
If you experience nasopharyngitis while taking CICLESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.